Vaccine adjuvants: current status, research and development, licensing, and future opportunities

Area of Science:

• Vaccine immunology
• Biochemistry
• Materials science

Background:

• Vaccines are crucial for global health, utilizing immune responses to combat pathogens.
• Adjuvants, used for over 90 years, significantly boost vaccine efficacy and immunogenicity.
• Adjuvants modulate and prolong immune responses, enhancing vaccine performance.

Purpose of the Study:

• To provide a comprehensive review of vaccine adjuvants.
• To cover their historical development, classification, and mechanisms of action.
• To analyze licensing processes and clinical trial examples, and predict future trends.

Main Methods:

• Systematic review of historical development and current status of adjuvants.
• Analysis of adjuvant classification, mechanisms, and roles in vaccines.
• Examination of licensing processes and clinical trial data.

Main Results:

• Adjuvants are essential for improving vaccine efficacy by enhancing immune responses.
• Historical development shows a progression in understanding and application of adjuvants.
• Current clinical trials highlight the diverse roles and potential of various adjuvant formulations.

Conclusions:

• Adjuvants are critical for advancing vaccine technology and public health.
• Future developments include novel adjuvant formulations and integration with systems vaccinology.
• Interdisciplinary understanding of biochemistry, materials science, and immunology is key to future vaccine innovation.